Table 1 Baseline characteristics in the enrolled patients
Non-pretreatment group (n = 52 eyes) | Pretreatment group (n = 53 eyes) | P value | |
|---|---|---|---|
Age | 67.7 ± 12.8 | 67.5 ± 10.8 | 0.924 |
Sex | M/F: 20/32 | M/F: 18/35 | 0.687 |
Nuclear sclerosis grading | 2.3 ± 0.9 | 2.5 ± 0.8 | 0.197 |
AL (mm) | 23.74 ± 1.40 | 23.70 ± 1.14 | 0.874 |
Kavg (D) | 44.49 ± 1.56 | 44.23 ± 1.50 | 0.377 |
ACD (mm) | 3.06 ± 0.45 | 3.11 ± 0.35 | 0.257 |
TBUT (sec) | 4.9 ± 1.8 | 4.6 ± 0.9 | 0.457 |
OSS (point) | 0.1 ± 0.4 | 0.2 ± 0.55 | 0.381 |
Tear secretion (mm) | 9.3 ± 2.8 | 8.2 ± 2.7 | 0.130 |